Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...

TED-A9 is high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs) under rigorous GMP conditions All 12 participants in Phase 1/2a were administered ...

The drug will now progress to pivotal Phase III trials after demonstrating trends towards a disease-modifying impact.

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

In Southeast Portland, a group of Parkinson's patients have found an unlikely ally in their battle against the disease: ...

After Ronnie Hamilton of Helena, Alabama, was diagnosed with Parkinson’s disease in summer of 2024, he did not communicate the same way he used to. “I would just go sit at the church and wouldn't talk ...

This landmark trial is the largest-to-date and was only made possible because of the seminal work of Australian scientists from the ...

The clinical effectiveness of individualized physiotherapy and occupational therapy in Parkinson disease (PD) has previously been unclear. The open-label, parallel group, randomized PD REHAB clinical ...

Parkinson’s — which can cause tremors, slow movement and stiffness — is believed to affect 1 in every 336 Americans.

When Pat Dunstan was diagnosed with Parkinson’s Disease, never in her wildest dreams did she imagine that her journey would lead to singing in a choir at Yankee Stadium before thousands of people. But ...

GALLOWAY TOWNSHIP — Stockton University’s speech and hearing clinic will offer free therapy to those with Parkinson’s disease via a multi-year grant from the Parkinson Voice Project, university ...